Rubrik: Fachthemen
(Treffer aus pharmind, Nr. 11, Seite 1714 (2014))
IP Strategies in the Generics and Pharmaceutical Industries / Between branded drug life cycle management and innovative generics (Part 2)*Teil 1 s. Pharm. Ind. 2014;76(10):1548–1553 · Ettner N, Meyer E · 1Kandern-Wollbach (Germany) und 2Miesbach (Germany)Rubrik: Fachthemen
(Treffer aus pharmind, Nr. 10, Seite 1548 (2014))
IP Strategies in the Generics and Pharmaceutical Industries / Between branded drug life cycle management and innovative generics (Part 1) · Ettner N, Meyer E · 1Kandern-Wollbach (Germany) und 2Miesbach (Germany)